APA (7th ed.) Citation

M, M., F, P., ME, M., E, M., A, T., R, G., . . . F, B. (2024). Pharmacokinetics of Efmoroctocog alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life. Journal of clinical medicine, 13(17), . https://doi.org/10.3390/jcm13174986

Chicago Style (17th ed.) Citation

M, Morfini, et al. "Pharmacokinetics of Efmoroctocog Alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life." Journal of Clinical Medicine 13, no. 17 (2024). https://doi.org/10.3390/jcm13174986.

MLA (9th ed.) Citation

M, Morfini, et al. "Pharmacokinetics of Efmoroctocog Alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life." Journal of Clinical Medicine, vol. 13, no. 17, 2024, https://doi.org/10.3390/jcm13174986.